Story

Anthropic Reportedly Arranging Investor Meetings for Potential October IPO

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
Anthropic Reportedly Arranging Investor Meetings for Potential October IPO

Summary

The AI startup is taking a critical step toward a public listing by scheduling preliminary meetings with institutional investors, according to a new report. The move could position Anthropic for an IPO as early as this October.

Text size
Background

Artificial intelligence firm Anthropic PBC is preparing for a potential Initial Public Offering (IPO) as early as October, with its underwriters now scheduling high-stakes meetings with investors in the coming weeks, according to a report from Bloomberg News.

Gauging Investor Appetite

The preliminary meetings, a process known as "testing the waters," are being arranged by the offering's lead managers: Morgan Stanley, Goldman Sachs Group Inc., and JPMorgan Chase & Co. This step is a standard part of the IPO timeline, allowing the company and its bankers to gauge demand from institutional investors and refine valuation expectations before a public filing.

The discussions follow Anthropic's earlier confidential draft registration with the U.S. Securities and Exchange Commission (SEC). This allows the company to undergo regulatory review privately. If the upcoming meetings indicate strong investor interest, the next major step would be the public filing of its S-1 registration statement.

Sample IUX Markets – In-articleAd

Path to a Public Listing

Under securities regulations, Anthropic must make its S-1 filing public at least 15 days before launching its official institutional roadshow. Should the meetings prove successful and market conditions remain favorable, the company could initiate its roadshow in the early autumn, setting the stage for a stock market debut in October.

The push for an IPO comes amid a period of rapid expansion for Anthropic, driven by strong enterprise demand for its generative AI models. The company's last funding round in May valued it at a reported $965 billion. If Anthropic achieves a similar valuation in its IPO, it would debut as one of the world's most valuable public companies.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST